Speech-Language Pathologists in Monticello, IL Accepting Medicare
4 Speech-Language Pathologists found. Showing 1 - 4
 Mrs. Jennifer Gibson Smith, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17 Sand Lake Rd, Monticello, IL 61856 Phone: 217-762-9410 |
Jacqueline Marie Tish Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15 Westwood Dr, Monticello, IL 61856 Phone: 217-521-2571 |
Rachel Caldwell, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2015 E Washington St, Monticello, IL 61856 Phone: 217-762-8511 |
Kathleen Fair, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 214 E Marion St, Monticello, IL 61856 Phone: 217-762-7363 |
News Archive
Study solves the longstanding mystery of anesthesia
Surgery would be inconceivable without general anesthesia, so it may come as a surprise that despite its 175-year history of medical use, doctors and scientists have been unable to explain how anesthetics temporarily render patients unconscious.
Pioneer Surgical Technology expands Biologics Product Specialist program
Pioneer Surgical Technology, Inc. recently expanded its Biologics Product Specialist program to provide sales and technical biologic expertise to support their growing line of products that address bone and soft tissue repair.
Brake for skin inflammation discovered
The absence of a protein called Ctip2 in the skin allows increased levels of T-helper 2 cytokines and may have a role in conditions such as atopic dermatitis, research in mice suggests.
Researcher can anticipate immune response in Alzheimer's patients
A researcher who is working on a vaccine for Alzheimer's disease (AD) has demonstrated that it is possible to test and measure specific immune responses in mice carrying human genes and to anticipate the immune response in Alzheimer's patients. This continuing research at Ben-Gurion University of the Negev could one day lead to specific Alzheimer's vaccines that reduce plaque, neuronal damage and inflammation associated with the disease.
Bayer Healthcare Pharmaceuticals commences enrollment in florbetaben Phase III clinical trials
Today at the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Bayer HealthCare Pharmaceuticals Inc. announced the enrollment of the first patient in an international Phase III clinical trial to evaluate the efficacy and safety of florbetaben (BAY 94-9172) PET imaging in the detection of beta-Amyloid plaques in the brain, which are a pathological hallmark of Alzheimer's disease.
› Verified 4 days ago
Physical Therapists
Occupational Therapists
Speech-Language Pathologists
Chiropractors
Optometrists